Excessive intake of sucrose is a major driver of obesity and other diseases, such as non-alcoholic fatty liver diseases (NAFLD) and the more severe non-alcoholic steatohepatitis (NASH). In addition, a ...
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. NAFLD patients are at higher risk of developing Non-alcoholic steatohepatitis (NASH), which ...
Apart from lifestyle interventions, there are currently no approved treatments for NASH. A liver transplant is sometimes the only remedy. While risk factors for NASH (obesity, type-2 diabetes and gene ...
The prevalence of non-alcoholic fatty liver disease (NAFLD), one of the most widespread disorders worldwide, is expected to rise by more than 50% by 2030. Non-alcoholic fatty liver (NAFL), the initial ...
Bepirovirsen, an investigational antisense oligonucleotide, led to sustained virologic response and a sustained decrease in hepatitis B virus (HBV) DNA, without the need for rescue medication, in ...
No posts found for this archive. Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical ...
Hosted on MSN
Fatty liver disease: THIS common leg symptom is an early warning, a top gastroenterologist reveals
Liver diseases are becoming increasingly common across the globe. In the United States, non-alcoholic fatty liver disease (NAFLD) is the most common liver disease. About 24% of US adults have NAFLD, ...
Hosted on MSN
3 myths of Fatty Liver Disease one needs to stop believing, as busted by AIIMS and Harvard Doctor
Fatty liver disease has become a widespread health issue, which affects people across the world. The rising number of people affected by this condition leads to multiple false beliefs about it which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback